Work

Genetics of Non-Syndromic Hearing Loss

Year: 2026
Type: article
Abstract: Background and aims: Hearing loss is a major global public health concern affecting over 1.5 billion people worldwide, with non-syndromic hearing loss (NSHL) accounting to nearly 70% of inherited cases. NSHL is predominantly genetic, contributing to approximately 70% of congenital hearing loss, with significant clinical and molecular heterogeneity. This review aims to summarize current knowledge on the genetic association, molecular mechanisms and recent technological advances in NSHL research. Methods: A narrative review of peer-reviewed literature was conducted using major scientific databases. Evidence regarding epidemiology, genetic determinants, key gene mutations, molecular pathways and emerging genomic technologies were critically analyzed. Special emphasis was placed on commonly implicated genes such GJB2, GJB6, SLC26A4, OTOF, MYO15A and TMC1 along with population specific mutation patterns. Results: NSHL arises from diverse molecular mechanisms, including gap junction dysfunction, disrupted ion homeostasis, impaired synaptic transmission and defective hair cell development. Advances in next-generation (NGS), targeted gene panels and panels and genome-wide association studies (GWAS) have significantly enhanced the role of genetics associated with NSHL, enabling risk stratification, earlier diagnosis and better understanding of genotype-phenotype correlations Conclusions: Emerging high throughput technologies like NGS has led to substantial progress and deeper molecular insights into genetics of NSHL. However, challenges remain due to marked genetic heterogeneity and population specific variations. Future directions include integration of precision medicine approaches, expansion of genomic screening programs and development of gene based therapies. These advances hold promise for improved diagnosis, personalized management and potential curative interventions in NSHL across diverse populations and healthcare settings, particularly in resource limited regions where early detection and access to genetic testing remain constrained, underscoring the need for equitable implementation of advanced diagnostic and therapeutic strategies globally in future practice.
Language: English
Subfield: Sensory Systems
Open Access status: diamond
OpenAlex ID: W7217751928
FWCI:
Cites: 79
Cited by:
Related to: 10